한미약품
379,500KRWMarket close of 10/21 (Wed)
Up +0.26%+1,000KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)370,500KRWDown -2.37%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 383,000
- High
- 393,500
- Low
- 376,500
- Day range
- Day range low 376,500 high 393,500, open 383,000, close 379,500, previous close 378,500
- Volume
- 7×10K shares
- 28.1B KRW 0.49× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
22%1-year close range 311,500 to 626,000 won, 22% up from the low
22% of the way up from the lowest close in 1 year (252 sessions) · -39.4% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range+0.26%+0.26%, 0.1× the usual (20-session average ±3.05%)That day +0.26% · usual ±3.05% · large-move threshold ±6.1%
- Trading valueusual range0.5×28.1B KRW, 0.5× the 20-session average0.49× the 20-session average · check threshold 3×
- Earningsusual range323.1B KRWOperating income over the last four quarters 323.1B KRW
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+8.0B KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 24 days
- Next data 10/23 (Fri) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.